Kuros Biosciences AG Market Cap ($720.86 Million)
Market Cap & Net Worth: Kuros Biosciences AG (KURN)
Kuros Biosciences AG market cap. Kuros Biosciences AG (SW:KURN) has a market capitalization of $720.86 Million (CHF570.18 Million) as of October 31, 2026. Listed on the SW stock exchange, this Switzerland-based company holds position #10047 globally and #130 in its home market, demonstrating a 1.38% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Kuros Biosciences AG's stock price CHF20.64 by its total outstanding shares 39673230 (39.67 Million).
Kuros Biosciences AG Market Cap History (2015–2026)
Kuros Biosciences AG market cap history from 2015 to 2026. Data shows change from $1.46 Billion to $1.04 Billion (-4.17% CAGR). Check KURN stock price and chart for real-time trading data and today's change.
Kuros Biosciences AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Kuros Biosciences AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see KURN cash generation efficiency for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
11.36x
Kuros Biosciences AG's market cap is 11.36 times its annual revenue
Latest Price to Earnings (P/E) Ratio
650.60x
Kuros Biosciences AG's market cap is 650.60 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $808.61 Million | $1.06 Million | -$19.74 Million | 762.12x | N/A |
| 2017 | $482.11 Million | $534.00K | -$16.48 Million | 902.82x | N/A |
| 2018 | $98.26 Million | $715.00K | -$11.69 Million | 137.43x | N/A |
| 2019 | $113.22 Million | $2.56 Million | -$11.25 Million | 44.21x | N/A |
| 2020 | $101.32 Million | $4.04 Million | -$11.52 Million | 25.09x | N/A |
| 2021 | $96.55 Million | $13.81 Million | -$7.54 Million | 6.99x | N/A |
| 2022 | $73.73 Million | $17.99 Million | -$14.60 Million | 4.10x | N/A |
| 2023 | $175.05 Million | $33.56 Million | -$13.73 Million | 5.22x | N/A |
| 2024 | $1.07 Billion | $75.56 Million | -$3.72 Million | 14.17x | N/A |
| 2025 | $1.38 Billion | $121.30 Million | $2.12 Million | 11.36x | 650.60x |
Competitor Companies of KURN by Market Capitalization
Companies near Kuros Biosciences AG in the global market cap rankings as of October 31, 2026. See Kuros Biosciences AG (KURN) balance sheet quality index to understand what proportion of total assets are financed by equity.
Key companies related to Kuros Biosciences AG by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $184.67 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #215 globally with a market cap of $111.95 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $184.67 Billion | $106.20 |
| #215 | Stryker Corporation | NYSE:SYK | $111.95 Billion | $291.86 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $96.54 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Kuros Biosciences AG (2015–2026)
Market capitalization of Kuros Biosciences AG from 2015 to today. Between 2015 and today, Kuros Biosciences AG's market cap moved from $1.46 Billion to $ 1.04 Billion, with a yearly change of -4.17%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CHF1.04 Billion | -24.89% |
| 2025 | CHF1.38 Billion | +28.71% |
| 2024 | CHF1.07 Billion | +511.75% |
| 2023 | CHF175.05 Million | +137.41% |
| 2022 | CHF73.73 Million | -23.64% |
| 2021 | CHF96.55 Million | -4.70% |
| 2020 | CHF101.32 Million | -10.51% |
| 2019 | CHF113.22 Million | +15.22% |
| 2018 | CHF98.26 Million | -79.62% |
| 2017 | CHF482.11 Million | -40.38% |
| 2016 | CHF808.61 Million | -44.59% |
| 2015 | CHF1.46 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Kuros Biosciences AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $720.86 Million USD |
| MoneyControl | $720.86 Million USD |
| MarketWatch | $720.86 Million USD |
| marketcap.company | $720.86 Million USD |
| Reuters | $720.86 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Kuros Biosciences AG
Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; Ma… Read more